|
|
||||||||
From the Neuropediatric Unit, Shaare Zedek Medical Center, Jerusalem, Israel.
Address correspondence and reprint requests to Dr. R.S. Shalev, Neuropediatric Unit, Shaare Zedek Medical Center, Post Office Box 3235, Jerusalem 91031, Israel; e-mail: shalev{at}szmc.org.il
Profound language regression developed in three children with epilepsy 4 to 28 weeks after beginning topiramate (TPM). TPM was administered as an adjunctive antiepileptic drug at doses of 2.5 to 6.0 mg/kg/day. Language functions recovered while TPM was being reduced in dose or stopped.
Received July 25, 2003. Accepted in final form September 19, 2003.
This article has been cited by other articles:
![]() |
R. Ottman, L. Rosenberger, A. Bagic, K. Kamberakis, E. K. Ritzl, A. M. Wohlschlager, S. Shamim, S. Sato, C. Liew, W. D. Gaillard, et al. Altered language processing in autosomal dominant partial epilepsy with auditory features Neurology, December 9, 2008; 71(24): 1973 - 1980. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Trevathan, S. P. Kerls, A. E. Hammer, A. Vuong, and J. A. Messenheimer Lamotrigine Adjunctive Therapy Among Children and Adolescents With Primary Generalized Tonic-Clonic Seizures Pediatrics, August 1, 2006; 118(2): e371 - e378. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Valencia, C. Fons, S. V. Kothare, D. S. Khurana, S. Yum, H. H. Hardison, and A. Legido Efficacy and Tolerability of Topiramate in Children Younger Than 2 Years Old J Child Neurol, August 1, 2005; 20(8): 667 - 670. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |